Status:

UNKNOWN

Assess Intraoperative Pain for Restorative Treatment of Maxillary 1st Permanent Molars Using Artinibsa Versus Artpharma in Children During Infiltration Technique

Lead Sponsor:

Cairo University

Conditions:

Pain

Eligibility:

All Genders

8-10 years

Phase:

NA

Brief Summary

The aim of this study is to assess Intraoperative pain for restorative treatment of Maxillary First Permanent Molars using Artinibsa Versus Artpharma in children during infiltration technique.

Detailed Description

Local anesthesia is very important during dental procedure because it's a temporary loss of sensation which will lead to decrease the pain. Local anesthesia started with discovery of Cocaine in 1860. ...

Eligibility Criteria

Inclusion

  • Children aged 8-10 years old
  • Mentally capable of communication
  • Cooperative children need restorative treatment

Exclusion

  • Medically compromised patient
  • Primary teeth requiring pulpotomy or pulpectomy
  • Parent or guardians who refuse participating in the study

Key Trial Info

Start Date :

April 1 2020

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

October 1 2021

Estimated Enrollment :

46 Patients enrolled

Trial Details

Trial ID

NCT04303234

Start Date

April 1 2020

End Date

October 1 2021

Last Update

March 11 2020

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.

Assess Intraoperative Pain for Restorative Treatment of Maxillary 1st Permanent Molars Using Artinibsa Versus Artpharma in Children During Infiltration Technique | DecenTrialz